Refine
Has Fulltext
- yes (79)
Is part of the Bibliography
- yes (79)
Year of publication
- 2022 (79) (remove)
Document Type
- Doctoral Thesis (76)
- Journal article (2)
- Book (1)
Language
- English (79) (remove)
Keywords
- GPCR (3)
- Transcription (3)
- 3D-Druck (2)
- Aufmerksamkeit (2)
- DNA damage (2)
- Ecology (2)
- Furcht (2)
- G-Protein gekoppelter Rezeptor (2)
- Genmutation (2)
- Jugend (2)
- Kind (2)
- Megakaryozyt (2)
- NFATc1 (2)
- Nephroblastom (2)
- Tissue Engineering (2)
- Virtuelle Realität (2)
- Ökologie (2)
- 3D cell culture (1)
- 3D-Zellkultur (1)
- 7SK (1)
- ASM (1)
- ATRA (1)
- Accelerated imaging (1)
- Adjuvans (1)
- Adjuvant (1)
- Adventitia (1)
- Ambrosia beetles (1)
- Ambrosiakäfer (1)
- Aminobuttersäure <gamma-> (1)
- Anaphylatoxine (1)
- Anaphylatoxinrezeptoren (1)
- Angeborene Immunität (1)
- Angst (1)
- Angst als Eigenschaft (1)
- Angsterkrankungen (1)
- Angststörung (1)
- Anisotropic structures (1)
- Arabidopsis thaliana (1)
- Arginine (1)
- Artefakt (1)
- Artenreichtum (1)
- Aspergillus fumigatus (1)
- Assoziatives Lernen (1)
- Augenbewegung (1)
- Autofocus (1)
- Autophagy (1)
- Bakterielle Nanocellulose (1)
- Barth syndrome (1)
- Beschleunigte Bildgebung (1)
- Beta-Adrenergic Receptor (1)
- Beta-Adrenozeptor (1)
- Bildgebendes Verfahren (1)
- Biodiversity conservation (1)
- Biofabrication (1)
- Biofabrikation (1)
- Bioink (1)
- Bioinks (1)
- Biologisches Modell (1)
- Bioprinting (1)
- Blimp-1 (1)
- Bone regeneration (1)
- Borkenkäfer (1)
- CD28 (1)
- CDH13 (1)
- CTLA-4 (1)
- CXCR4 (1)
- CXCR5 (1)
- Calcium (1)
- Calcium phosphate-based biomaterials (1)
- Cancer (1)
- Candida albicans (1)
- Carabid beetles (1)
- Cardiac Efficiency (1)
- Cardiac imaging (1)
- Cardiolipin (1)
- Cardiomyocyte (1)
- Cardiomyopathy (1)
- Cartilage Tissue Engineering (1)
- Cataglyphis (1)
- Cell Sheet Engineering (1)
- Cell cycle (1)
- Cells (1)
- Ceramid (1)
- Chemische Synapsen (1)
- Chemokine (1)
- Chondrogenic Differentiation (1)
- Chromatinremodeling (1)
- Chromatinremodelling (1)
- Chronische Niereninsuffizienz (1)
- Chylomicron (1)
- Chylomicrons (1)
- Claudin (1)
- Complexes (1)
- Compressed sensing (1)
- Coronary heart disease (1)
- DG diacyglycerol (1)
- DGCR8 (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- DROSHA (1)
- DSIF (1)
- Darm (1)
- Deoxyribozymes (1)
- Diffusion (1)
- Dihydrooxazole (1)
- Dimere (1)
- Dorsal Root Ganglion (1)
- Drosophila melanogaster (1)
- Dual RNA-seq data analysis (1)
- Dünndarm (1)
- Echocardiography (1)
- Echokardiographie (1)
- Echtzeitbildgebung (1)
- Ecosystem services (1)
- Einzelzellanalyse (1)
- Elevated Plus-Maze (1)
- Epithel (1)
- Epithelial layer (1)
- Estrogens (1)
- Explorationsverhalten (1)
- Extrazelluläre Matrix (1)
- FCS (1)
- Fibroblastenwachstumsfaktor (1)
- Fluorescence (1)
- Fluorescence Correlation Spectroscopy (1)
- Fluorescence Microscopy (1)
- Fluoreszenzkorrelationsspektroskopie (1)
- Fluoreszenzmikroskopie (1)
- Freezing (1)
- Furchtkonditionierung (1)
- G Protein-Coupled Receptor (1)
- G-Protein gekoppelte Rezeptoren (1)
- G-protein-coupled receptors (1)
- GABA receptor (1)
- GABA-Rezeptor (1)
- Gastrointestinal tract (1)
- Gastrointestinaltrakt (1)
- Gefrierstrukturierung (1)
- Gelenkknorpel (1)
- Geomagnetic Field (1)
- Gephyrin (1)
- Global change (1)
- Glycin (1)
- Glycinrezeptor (1)
- Gradient System Transfer Function (1)
- Growth (1)
- GvHD (1)
- HSV-1 (1)
- Heart Failure (1)
- Herpesviren (1)
- Herpesviruses (1)
- Herzbildgebung (1)
- Herzinsuffizienz (1)
- Histone (1)
- Histones (1)
- Hyaluronic Acid (1)
- Hyaluronsäure (1)
- Hydrogels (1)
- Hypertension (1)
- ICP22 (1)
- Immunantwort (1)
- Immunisierung (1)
- Impfung (1)
- In vitro (1)
- In vitro models (1)
- In-vitro-Kultur (1)
- Innate immunity (1)
- Interaction of 7SK with the Smn complex modulates snRNP production (1)
- Ionenkanal (1)
- Japankärpfling (1)
- Jugendliche (1)
- Kardiomyozyt (1)
- Keimzentrumsreaktion (1)
- Kernspintomografie (1)
- Kinder (1)
- Kindheit und Jugend (1)
- Klimaänderung (1)
- Kognition (1)
- Kompass (1)
- Komplement <Immunologie> (1)
- Komplement C3a (1)
- Komplement C5a (1)
- Konditionierung (1)
- Koronare Herzkrankheit (1)
- Kutikula (1)
- LV Function (1)
- Lateral root development (1)
- Latrophilin (1)
- Learning & Memory (1)
- Learning Walk (1)
- Lernen (1)
- Lidschlag (1)
- Ligand uncaging (1)
- Lysosom (1)
- MAX (1)
- MET-T-box riboswitch (1)
- MRI (1)
- MRT (1)
- MYC (1)
- MYCN (1)
- Macromolecular machine (1)
- Macrophage extracellular traps (1)
- Macrophytes (1)
- Major depression (1)
- Makrophyten (1)
- Mc4r (1)
- Mechanistic model (1)
- Medaka (1)
- Melanom (1)
- Melt Electrowriting (1)
- Mesenchymal Stromal Cell (1)
- Mesenchymale Stromazelle (1)
- Methioninbiosynthese (1)
- MicF (1)
- Microscopy (1)
- Mitochondria (1)
- Moco biosynthesis (1)
- Molecular Pharmacology (1)
- Molekularbiologie (1)
- Monoklonaler Antikörper (1)
- Morphology (1)
- Motoneuron (1)
- Mrap2 (1)
- MscS (1)
- Mustererkennungsrezeptoren (1)
- Mutation (1)
- Myc (1)
- Myocardial Work (1)
- Nahrungserwerb (1)
- Natural pest control (1)
- Navigation (1)
- Nebennierenrindenkrebs (1)
- Neisseria meningitidis (1)
- Nervennetz (1)
- Neuroethologie (1)
- Neuroethology (1)
- Neuropathic Pain (1)
- Neuropathy (1)
- Nierenversagen (1)
- Obesity (1)
- Open chromatin (1)
- Opiatrezeptor (1)
- Optogenetik (1)
- Organoid (1)
- Organoids (1)
- Orientia tsutsugamushi (1)
- PCDHGC3 (1)
- PE Phosphoethanolamine (1)
- Parkinson's disease (1)
- Parkinson-Krankheit (1)
- Pattern recognition receptors (1)
- Peroxisomen-Proliferator-aktivierter Rezeptor (1)
- Pflanzenschutzmittel (1)
- Pharmaceutische Biologie (1)
- Pharmacology (1)
- Pilze (1)
- Plant Protection (1)
- Plant cuticle (1)
- Poly(2-oxazoline) (1)
- Poly(2-oxazoline)s (1)
- Polyethism (1)
- Polymer Science (1)
- Primär-basierte immortalisierte Zelllinie (1)
- Progenitor (1)
- Protein Kinase D2 (1)
- Protein interactor (1)
- Proteine (1)
- Proteinkinase D (1)
- Proteom (1)
- Prävention (1)
- Puberty (1)
- Pubertät (1)
- RNA (1)
- RNA Abbau (1)
- RNA G-quadruplex (1)
- RNA decay (1)
- RNA modifications (1)
- RNA polymerase II (1)
- RNA structures (1)
- Read-through transcription (1)
- Real-time imaging (1)
- Receptor (1)
- Rezeptor (1)
- Rho-Proteine (1)
- Ribozymes (1)
- Risikofaktoren (1)
- SCV maturation (1)
- SMN (1)
- SMN complex (1)
- STAAB Cohort Study (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Schwertkärpfling (1)
- Signaltransduktion (1)
- Small RNA (1)
- SnRK1-bZIP complex (1)
- Species richness (1)
- Spirale (1)
- Spliceosome (1)
- Squamous cell carcinoma (1)
- Staphylococcus aureus (1)
- Stem Cells (1)
- Stress (1)
- Structural organisation (1)
- Symbiose (1)
- Synapse (1)
- T cell specificity (1)
- T-Lymphozyt (1)
- TNF (1)
- TNFR2 (1)
- Tabakkonsum (1)
- Taufliege (1)
- Thermoresponsive Polymere (1)
- Thymocytes (1)
- Tight Junction Proteins (1)
- Tobacco smoking (1)
- Transkription (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Treg (1)
- Tumorimmunologie (1)
- USP28 (1)
- Ubiquitin (1)
- Ubiquitin system (1)
- Unidirectional Freezing (1)
- Uremic cardiomyopathy (1)
- Urämie (1)
- Urämische Kardiomyopathie (1)
- Vakuole (1)
- Validität (1)
- Variants (1)
- Vaskularisation (1)
- WNT signaling (1)
- Wahrnehmung (1)
- Wasted Work (1)
- Wilms Tumor (1)
- Wilms tumor (1)
- Xiphophorus (1)
- Yb1 (1)
- YnaI (1)
- Zellkultur (1)
- Zellmigration (1)
- Zellzyklus (1)
- active zone (1)
- adolescents (1)
- adrenocortical carcinoma (1)
- agonist (1)
- anaphylatoxin receptors (1)
- astrocytoma (1)
- atomic force microscopy (1)
- bacterial nanocellulose (1)
- bark beetles (1)
- biomaterials (1)
- brain (1)
- children (1)
- chimeric antigen receptor (1)
- deep brain stimulation (1)
- delipidation (1)
- ecological validity (1)
- electron cryomicroscopy (1)
- electron microscopy (1)
- endosomal trafficking (1)
- epithelial to mesenchymal transition (1)
- expression (1)
- eye tracking (1)
- fear conditioning (1)
- fear extinction (1)
- fear generalization (1)
- fibroblast growth factors (1)
- follicular regulatory T cell (1)
- follikuläre regulatorische T-Zelle (1)
- fungi (1)
- gait analysis (1)
- gait initiation (1)
- germinal center (1)
- glioblastoma multiforme (1)
- glioma (1)
- glycine receptor (1)
- hnRNP (1)
- hnRNP R (1)
- host colonization (1)
- human plasma (1)
- immune response (1)
- in vitro Modelle (1)
- in vitro-Testsystem (1)
- infection biology (1)
- intestinal in vitro model (1)
- invasive meningococcal diseases (1)
- invasive pulmonary aspergillosis (1)
- ion channel (1)
- ischemia reperfusion injury (1)
- learning and memory (1)
- liver (1)
- locomotor network (1)
- lysosome (1)
- mRNA (1)
- measles virus (1)
- mechanosensing (1)
- mechanosensitive channels (1)
- medical device (1)
- megakaryocyte (1)
- megakaryocytes (1)
- megakaryopoiesis (1)
- melt electrowriting (1)
- methionine biosynthesis (1)
- miRNA (1)
- miRNS (1)
- microprocessor complex (1)
- monoclonal antibodies (1)
- monoklonale Antikörper (1)
- motoneurons (1)
- movement disorders (1)
- movement interaction (1)
- mukosale Immunantwort (1)
- mutualism (1)
- myokardiale Arbeit (1)
- neural biomarkers (1)
- neurodevelopmental disorders (1)
- neuronal network (1)
- oligomerization (1)
- optogenetics (1)
- parkinson's disease (1)
- perfused hydrogel (1)
- platelets (1)
- primary-cell-derived immortalized cell line (1)
- profiles (1)
- proplatelets (1)
- protein (1)
- protein-DNA interactions (1)
- protein-lipid interactions (1)
- recurrence (1)
- regulatory T cells (1)
- relapse (1)
- rho gtpases (1)
- riboswitch (1)
- risk factors (1)
- second messenger (1)
- serotonergic system (1)
- serum retention (1)
- skin model (1)
- snRNP (1)
- social attention (1)
- sphingolipid (1)
- spontaneous blinks (1)
- subcutaneous implanation (1)
- symbiosis (1)
- synaptic proteins (1)
- synaptische Proteine (1)
- t cells (1)
- targeted therapy (1)
- threat conditioning (1)
- thrombopoiesis (1)
- transcription regulator (1)
- transcriptome profiling (1)
- tumor metabolism (1)
- unconventional T cells (1)
- vacuole (1)
- vascularization (1)
- virtual reality (1)
- x-ray micro computed tomography (1)
- Übergewicht (1)
- Übertragungsfunktion (1)
- ΔNp63 (1)
- α-synuclein (1)
Institute
- Graduate School of Life Sciences (79) (remove)
Sonstige beteiligte Institutionen
- Helmholtz Institute for RNA-based Infection Research (HIRI) (2)
- Department of Cellular Therapies, University of Navarra, Pamplona, Spain (1)
- Department of X-ray Microscopy, University of Würzburg, Würzburg, Germany (1)
- Interdisziplinäre Zentrum für Klinische Forschung (IZKF) (1)
- Politecnico di Milano (1)
- Universitätsklinikum Würzburg (UKW) (1)
Although the field of fungal infections advanced tremendously, diagnosis of invasive pulmonary aspergillosis (IPA) in immunocompromised patients continues to be a challenge. Since IPA is a multifactorial disease, investigation from different aspects may provide new insights, helpful for improving IPA diagnosis. This work aimed to characterize the human immune response to Aspergillus fumigatus in a multilevel manner to identify characteristic molecular candidates and risk factors indicating IPA, which may in the future support already established diagnostic assays. We combined in vitro studies using myeloid cells infected with A. fumigatus and longitudinal case-control studies investigating patients post allogeneic stem cell transplantation (alloSCT) suffering from IPA and their match controls.
Characteristic miRNA and mRNA signatures indicating A. fumigatus-infected monocyte-derived dendritic cells (moDCs) demonstrated the potential to differentiate between A. fumigatus and Escherichia coli infection. Transcriptome and protein profiling of alloSCT patients suffering from IPA and their matched controls revealed a distinctive IPA signature consisting of MMP1 induction and LGAL2 repression in combination with elevated IL-8 and caspase-3 levels. Both, in vitro and case-control studies, suggested cytokines, matrix-metallopeptidases and galectins are important in the immune response to A. fumigatus. Identified IPA characteristic molecular candidates are involved in numerous processes, thus a combination of these in a distinctive signature may increase the specificity. Finally, low monocyte counts, severe GvHD of the gut (grade ≥ 2) and etanercept administration were significantly associated with IPA diagnosis post alloSCT. Etanercept in monocyte-derived macrophages (MDM) infected with A. fumigatus downregulates genes involved in the NF-κB and TNF-α pathway and affects the secretion of CXCL10.
Taken together, identified characteristic molecular signatures and risk factors indicating IPA may in the future in combination with established fungal biomarkers overcome current diagnostic challenges and help to establish tailored antifungal therapy. Therefore, further multicentre studies are encouraged to evaluate reported findings.
Thermoplastic polymers have a history of decades of safe and effective use in the clinic as implantable medical devices. In recent years additive manufacturing (AM) saw increased clinical interest for the fabrication of customizable and implantable medical devices and training models using the patients’ own radiological data. However, approval from the various regulatory bodies remains a significant hurdle. A possible solution is to fabricate the AM scaffolds using materials and techniques with a clinical safety record, e.g. melt processing of polymers. Melt Electrowriting (MEW) is a novel, high resolution AM technique which uses thermoplastic polymers. MEW produces scaffolds with microscale fibers and precise fiber placement, allowing the control of the scaffold microarchitecture. Additionally, MEW can process medical-grade thermoplastic polymers, without the use of solvents paving the way for the production of medical devices for clinical applications. This pathway is investigated in this thesis, where the layout is designed to resemble the journey of a medical device produced via MEW from conception to early in vivo experiments. To do so, first, a brief history of the development of medical implants and the regenerative capability of the human body is given in Chapter 1. In Chapter 2, a review of the use of thermoplastic polymers in medicine, with a focus on poly(ε-caprolactone) (PCL), is illustrated, as this is the polymer used in the rest of the thesis. This review is followed by a comparison of the state of the art, regarding in vivo and clinical experiments, of three polymer melt AM technologies: melt-extrusion, selective laser sintering and MEW. The first two techniques already saw successful translation to the bedside, producing patient-specific, regulatory-approved AM implants. To follow in the footsteps of these two technologies, the MEW device parameters need to be optimized. The MEW process parameters and their interplay are further discussed in Chapter 3 focusing on the importance of a steady mass flow rate of the polymer during printing. MEW reaches a balance between polymer flow, the stabilizing electric field and moving collector to produce reproducible, high-resolution scaffolds. An imbalance creates phenomena like fiber pulsing or arcing which result in defective scaffolds and potential printer damage. Chapter 4 shows the use of X-ray microtomography (µCT) as a non-destructive method to characterize the pore-related features: total porosity and the pore size distribution. MEW scaffolds are three-dimensional (3D) constructs but have long been treated in the literature as two-dimensional (2D) ones and characterized mainly by microscopy, including stereo- and scanning electron microscopy, where pore size was simply reported as the distance between the fibers in a single layer. These methods, together with the trend of producing scaffolds with symmetrical pores in the 0/90° and 0/60/120° laydown patterns, disregarded the lateral connections between pores and the potential of MEW to be used for more complex 3D structures, mimicking the extracellular matrix. Here we characterized scaffolds in the aforementioned symmetrical laydown patterns, along with the more complex 0/45/90/135° and 0/30/60/90/120/150° ones. A 2D pore size estimation was done first using stereomicroscopy, followed by and compared to µCT scanning. The scaffolds with symmetrical laydown patterns resulted in the predominance of one pore size, while those with more complex patterns had a broader distribution, which could be better shown by µCT scans. Moreover, in the symmetrical scaffolds, the size of 3D pores was not able to reach the value of the fiber spacing due to a flattening effect of the scaffold, where the thickness of the scaffold was less than the fiber spacing, further restricting the pore size distribution in such scaffolds. This method could be used for quality assurance of fabricated scaffolds prior to use in in vitro or in vivo experiments and would be important for a clinical translation. Chapter 5 illustrates a proof of principle subcutaneous implantation in vivo experiment. MEW scaffolds were already featured in small animal in vivo experiments, but to date, no analysis of the foreign body reaction (FBR) to such implants was performed. FBR is an immune reaction to implanted foreign materials, including medical devices, aimed at protecting the host from potential adverse effects and can interfere with the function of some medical implants. Medical-grade PCL was used to melt electrowrite scaffolds with 50 and 60 µm fiber spacing for the 0/90° and 0/60/120° laydown patterns, respectively. These implants were implanted subcutaneously in immunocompetent, outbred mice, with appropriate controls, and explanted after 2, 4, 7 and 14 days. A thorough characterization of the scaffolds before implantation was done, followed by a full histopathological analysis of the FBR to the implants after excision. The scaffolds, irrespective of their pore geometry, induced an extensive FBR in the form of accumulation of foreign body giant cells around the fiber walls, in a manner that almost occluded available pore spaces with little to no neovascularization. This reaction was not induced by the material itself, as the same reaction failed to develop in the PCL solid film controls. A discussion of the results was given with special regard to the literature available on flat surgical meshes, as well as other hydrogel-based porous scaffolds with similar pore sizes. Finally, a general summary of the thesis in Chapter 6 recapitulates the most important points with a focus on future directions for MEW.
DNA damage occurs frequently during normal cellular progresses or by environmental factors. To preserve the genome integrity, DNA damage response (DDR) has evolved to repair DNA and the non-properly repaired DNA induces human diseases like immune deficiency and cancer. Since a large number of proteins involved in DDR are enzymes of ubiquitin system, it is critical to investigate how the ubiquitin system regulates cellular response to DNA damage. Hereby, we reveal a novel mechanism for DDR regulation via activation of SCF ubiquitin ligase upon DNA damage.
As an essential step for DNA damage-induced inhibition of DNA replication, Cdc25A degradation by the E3 ligase β-TrCP upon DNA damage requires the deubiquitinase Usp28. Usp28 deubiquitinates β-TrCP in response to DNA damage, thereby promotes its dimerization, which is required for its activity in substrate ubiquitination and degradation. Particularly, ubiquitination at a specific lysine on β-TrCP suppresses dimerization.
The key mediator protein of DDR, 53BP1, forms oligomers and associates with β-TrCP to inhibit its activity in unstressed cells. Upon DNA damage, 53BP1 is degraded in the nucleoplasm, which requires oligomerization and is promoted by Usp28 in a β-TrCP-dependent manner. Consequently, 53BP1 destruction releases and activates β-TrCP during DNA damage response.
Moreover, 53BP1 deletion and DNA damage promote β-TrCP dimerization and recruitment to chromatin sites that locate in the vicinity of putative replication origins. Subsequently, the chromatin-associated Cdc25A is degraded by β-TrCP at the origins. The stimulation of β-TrCP binding to the origins upon DNA damage is accompanied by unloading of Cdc45, a crucial component of pre-initiation complexes for replication. Loading of Cdc45 to origins is a key Cdk2-dependent step for DNA replication initiation, indicating that localized Cdc25A degradation by β-TrCP at origins inactivates Cdk2, thereby inhibits the initiation of DNA replication.
Collectively, this study suggests a novel mechanism for the regulation of DNA replication upon DNA damage, which involves 53BP1- and Usp28-dependent activation of the SCF(β-TrCP) ligase in Cdc25A degradation.
Lack of acid sphingomyelinase (ASM) activity, either through genetic deficiency or through pharmacological inhibition, is linked with increased activity and frequency of Foxp3+ regulatory T cells (Treg) among cluster of differentiation (CD) 4+ T cells in mice in vivo and in vitro1. Thus, pharmacological blockade of ASM activity, which catalyzes the cleavage of sphingomyelin to ceramide and phosphocholine, might be used as a new therapeutic mechanism to correct numeric and/ or functional Treg de-ficiencies in diseases like multiple sclerosis or major depression.
In the present study, the effect of pharmacological inhibition of ASM in humans, in vitro and in vivo, was analyzed. In the in vitro experiments, peripheral blood mono-nuclear cells (PBMC) of healthy human blood donors were treated with two widely prescribed antidepressants with high (sertraline, Ser) or low (citalopram, Cit) capaci-ty to inhibit ASM activity. Similar to the findings in mice an increase in the frequency of Treg among human CD4+ T cells upon inhibition of ASM activity was observed. For the analysis in vivo, a prospective study of the composition of the CD4+ T cell com-partment of patients treated for major depression was done. The data show that pharmacological inhibition of ASM activity was superior to antidepressants with little or no ASM-inhibitory activity in increasing CD45RA- CD25high effector Treg (efTreg) frequencies among CD4+ T cells to normal levels. Independently of ASM inhibition, correlating the data with the clinical response, i.e. improvement of the Hamilton rat-ing scale for depression (HAMD) by at least 50 per cent (%) after four weeks of treatment, it was found that an increase in efTreg frequencies among CD4+ cells dur-ing the first week of treatment identified patients with a clinical response.
Regarding the underlying mechanism, it could be found that the positive effect of ASM inhibition on Treg required CD28 co-stimulation suggesting that enhanced CD28 co-stimulation was the driver of the observed increase in the frequency of Treg among human CD4+ T cells. Inhibition of ASM activity was further associated with changes in the expression and shuttling of CTLA-4, a key inhibitory molecule ex-pressed by Treg, between cellular compartments but the suppressive activity of CTLA-4 through its transendocytosis activity was unaffected by the inhibition of ASM activity.
In summary, the frequency of (effector) Treg among CD4+ T cells in mice and in hu-mans is increased after inhibition of ASM activity suggesting that ASM blockade might beneficially modulate autoimmune diseases and depression-promoting in-flammation.
Methionine is the first amino acid of every newly synthesised protein. In combination with its role as precursor for the vital methyl-group donor S-adenosylmethionine, methionine is essential for every living cell. The opportunistic human pathogen Staphylococcus aureus is capable of synthesising methionine de novo, when it becomes scarce in the environment. All genes required for the de novo biosynthesis are encoded by the metICFE-mdh operon, except for metX. Expression is controlled by a hierarchical network with a methionyl-tRNA-specific T-box riboswitch (MET-TBRS) as centrepiece, that is also referred to as met leader (RNA). T-box riboswitches (TBRS) are regulatory RNA elements located in the 5’-untranslated region (5’-UTR) of genes. The effector molecule of T-box riboswitches is uncharged cognate tRNA. The prevailing mechanism of action is premature termination of transcription of the nascent RNA in the absence of the effector (i.e. uncharged cognate tRNA) due to formation of a hairpin structure, the Terminator stem. In presence of the effector, a transient stabilisation of the alternative structure, the Antiterminator, enables transcription of the downstream genes (‘read-through’). Albeit, after the read-through the thermodynamically more stable Terminator eventually forms. The Terminator and the Antiterminator are two mutually exclusive structures. Previous work of the research group showed that in staphylococci the MET-TBRS ensures strictly methionine-dependent control of met operon expression. Uncharged methionyl-tRNA that activates the system is only present in sufficient amounts under methionine-deprived conditions. In contrast to other bacterial TBRS, the staphylococcal MET-TBRS has some characteristic features regarding its length and predicted secondary structure whose relevance for the function are yet unkown.
Aim of the present thesis was to experimentally determine the structure of the met leader RNA and to investigate the stability of the met operon-specific transcripts in the context of methionine biosynthesis control. Furthermore, the yet unknown function of the mdh gene within the met operon was to be determined.
In the context of this thesis, the secondary structure of the met leader was determined employing in-line probing. The structural analysis revealed the presence of almost all highly conserved T-box riboswitch structural characteristics. Furthermore, three additional stems, absent in all T-box riboswitches analysed to date, could be identified. Particularly remarkable is the above average length of the Terminator stem which renders it a potential target of the double-strand-specific endoribonuclease III (RNase III). The RNase III-dependent cleavage of the met leader could be experimentally verified by the use of suitable mutants. Moreover, the exact cleavage site within the Terminator was determined.
The unusual immediate separation of the met leader from the met operon mRNA via the RNase III cleavage within the Terminator stem induces the rapid degradation of the met leader RNA and, most likely, that of the 5’-region of the met mRNA. The met mRNA is degraded from its 5’-end by the exoribonuclease RNase J. The stability of the met mRNA was found to vary over the length of the transcript with an instable 5’-end (metI and metC) and a longer half-life towards the 3’-end (metE and mdh). The varying transcript stability is reflected by differences in the available cellular protein levels. The obtained data suggest that programmed mRNA degradation is another level of regulation in the complex network of staphylococcal de novo methionine biosynthesis control.
In addition, the MET-TBRS was studied with regard to a future use as a drug target for novel antimicrobial agents. To this end, effects of a dysregulated methionine biosynthesis on bacterial growth and survival were investigated in met leader mutants that either caused permanent transcription of the met operon (‘ON’) or prevented operon transcription (‘OFF’), irrespective of the methionine status in the cell. Methionine deprivation turned out to be a strong selection pressure, as ‘OFF’ mutants acquired adaptive mutations within the met leader to restore met operon expression that subsequently re-enabled growth.
The second part of the thesis was dedicated to the characterisation of the Mdh protein that is encoded by the last gene of the met operon and whose function is unknown yet. At first, co-transcription and -expression with the met operon could be demonstrated. Next, the Mdh protein was overexpressed and purified and the crystal structure of Mdh was solved to high resolution by the Kisker research group (Rudolf-Virchow-Zentrum Würzburg). Analysis of the structure revealed the amino acid residues crucial for catalytic activity, and zinc was identified as a co-factor of Mdh. Also, Mdh was shown to exist as a dimer. However, identification of the Mdh substrate was, in the context of this thesis, (still) unsuccessful. Nevertheless, interactions of Mdh with enzymes of the met operon could be demonstrated by employing the bacterial two-hybrid system. This fact and the high conservation of mdh/Mdh on nucleotide and amino acid level among numerous staphylococcal species suggests an important role of Mdh within the methionine metabolism that should be a worthwhile subject of future research.
The genetic modification of T cells for the expression a chimeric antigen receptor (CAR) endows them with a new specificity for an antigen. Adoptive immunotherapy with CD19-CAR T cells has achieved high rates of sustained complete remissions in B cell malignancies. However, the downregulation or loss of the targeted antigen after mono-specific CAR T cell therapy, e.g. against CD19 or CD22, has been reported. Targeting multiple antigens on tumour cells, sequentially or simultaneously, could overcome this limitation. Additionally, targeting multiple antigens with CAR T cells could drive the translation from hematologic malignancies to prevalent solid cancers, which often express tumour-associated antigens heterogeneously. We hypothesised that expression of a universal CAR, which can be programmed with hapten-like molecules, could endow T cells with specificities for multiple antigens.
In this study we introduce a novel chemically programmable CAR (cpCAR) based on monoclonal antibody h38C2. Our data show, that cpCARs form a reversible chemical bond to molecules containing a diketone-group and therefore can be programmed to acquire multiple specificities. We programmed cpCAR T cells with hapten-like compounds against integrins αvβ3 and α4β1 as well as the folate receptor. We observed tumour cell lysis, IFN ɣ and IL-2 production and proliferation of programmed cpCAR T cells against tumour cells expressing the respective target antigen in vitro.
As a reference to cpCARs programmed against αvβ3, we further introduced novel conventional αvβ3-CARs. These CARs, based on humanised variants of monoclonal antibody LM609 (hLM609), directly bind to integrin αvβ3 via their scFv. The four αvβ3-CAR constructs comprised either an scFv with higher affinity (hLM609v7) or lower affinity (hLM609v11) against αvβ3 integrin and either a long (IgG4 hinge, CH2, CH3) or short (IgG4 hinge) extracellular spacer. We selected the hLM609v7-CAR with short spacer, which showed potent anti-tumour reactivity both in vitro and in a murine xenograft model, for comparison with the cpCAR programmed against αvβ3. Our data show specific lysis of αvβ3-positive tumour cells, cytokine production and proliferation of both hLM609-CAR T cells and cpCAR T cells in vitro. However, conventional hLM609-CAR T cells mediated stronger anti-tumour effects compared to cpCAR T cells in the same amount of time. In line with the in vitro data, complete destruction of tumour lesions in a murine melanoma xenograft model was only observed for mice treated with conventional αvβ3-CAR T cells.
Collectively, we introduce a cpCAR, which can be programmed against multiple tumour antigens, and hLM609-CARs specific for the integrin αvβ3. The cpCAR technology bears the potential to counteract current limitations, e.g. antigen loss, of current monospecific CAR T cell therapy. Targeting αvβ3 integrin with CAR T cells could have clinical applications in the treatment of solid malignancies, because αvβ3 is not only expressed on a variety of solid malignancies, but also on tumour-associated vasculature and fibroblast.
Cellular proteome profiling revealed that most biomolecules do not exist in isolation, but rather are incorporated into modular complexes. These assembled complexes are usually very large, consisting of 10 subunits on an average and include either proteins alone, or proteins and nucleic acids. Consequently, such macromolecular assemblies rather than individual biopolymers perform the vast majority of cellular activities. The faithful assembly of such molecular assemblies is often aided by trans-acting factors in vivo, to preclude aggregation of complex components and/or non-cognate interactions. A paradigm for an assisted assembly of a macromolecular machine is the formation of the common Sm/LSm core of spliceosomal and histone-mRNA processing U snRNPs. The key assembly factors united in the Protein Arginine Methyltransferase 5 (PRMT5) and the Survival Motor Neuron (SMN) complexes orchestrate the assembly of the Sm/LSm core on the U snRNAs. Assembly is initiated by the PRMT5-complex subunit pICln, which pre-arranges the Sm/LSm proteins into spatial positions occupied in the mature U snRNPs. The SMN complex subsequently binds these Sm/LSm units, displaces pICln and catalyses the Sm ring closure on the Sm-site of the U snRNA.
The SMN complex consists of the eponoymous SMN protein linked in a modular network of interactions with eight other proteins, termed Gemins 2-8 and Unrip. Despite functional and structural characterisation of individual protein components and/or sub-complexes of this assembly machinery, coherent understanding of the structural framework of the core SMN complex remained elusive. The current work, employing a combined approach of biochemical and structural studies, aimed to contribute to the understanding of how distinct modules within the SMN complex coalecse to form the macromolecular SMN complex.
A novel atomic resolution (1.5 Å) structure of the human Gemin8:7:6 sub-complex, illustrates how the peripheral Gemin7:6 module is tethered to the SMN complex via Gemin8’s C-terminus. In this model, Gemin7 engages with both Gemin6 and Gemin8 via the N- and C-termini of its Sm-fold like domain. This highly conserved interaction mode is reflected in the pronounced sequence conservation and identical biochemical behaviour of similar sub-complexes from divergent species, namely S. pombe and C. elegans.
Despite lacking significant sequence similarity to the Sm proteins, the dimeric Gemin7:6 complex share structural resemblance to the Sm heteromers. The hypothesis that the dimeric Gemin7:6 functions as a Sm-surrogate during Sm core assembly could not be confirmed in this work. The functional relevance of the structural mimicry of the dimeric Gemin7:6 sub-complex with the Sm heterodimers therefore still remains unclear.
Reduced levels of functional SMN protein is the cause of the devastating neurodegenerative disease, Spinal Muscular Atrophy (SMA). The C-terminal YG-zipper motif of SMN is a major hot-spot for most SMA patient mutations. In this work, adding to the existing inventory of the human and fission yeast YG-box models, a novel 2.2 Å crystal structure of the nematode SMN’s YG-box domain adopting the glycine zipper motif has been reported. Furthermore, it could be assessed that SMA patient mutations mapping to this YG-box domain greatly influences SMN’s self-association competency, a property reflected in both the human and nematode YG-box biochemical handles. The shared molecular architecture and biochemical behaviour of the nematode SMN YG-box domain with its human and fission yeast counterparts, reiterates the pronounced conservation of this oligomerisation motif across divergent organisms.
Apart from serving as a multimerization domain, SMN’s YG-box also acts as interaction platform for Gemin8. A systematic investigation of SMA causing missense mutations uncovered that Gemin8’s incorporation into the SMN complex is influenced by the presence of certain SMA patient mutations, albeit independent of SMN’s oligomerisation status. Consequently, loss of Gemin8 association in the presence of SMA patient mutations would also affect the incorporation of Gemin7:6 sub-complex. Gemin8, therefore sculpts the heteromeric SMN complex by bridging the Gemin7:6 and SMN:Gemin2 sub-units, a modular feature shared in both the human and nematode SMN complexes.
These findings provide an important foundation and a prospective structural framework for elucidating the core architecture of the SMN complex in the ongoing Cryo-EM studies.
New insights into the histone variant H2A.Z incorporation pathway in \(Trypanosoma\) \(brucei\)
(2022)
The histone variant H2A.Z is a key player in transcription regulation in eukaryotes. Histone acetylations by the NuA4/TIP60 complex are required to enable proper incorporation of the histone variant and to promote the recruitment of other complexes and proteins required for transcription initiation. The second key player in H2A.Z-mediated transcription is the chromatin remodelling complex SWR1, which replaces the canonical histone H2A with its variant. By the time this project started little was known about H2A.Z in the unicellular parasite Trypanosoma brucei. Like in other eukaryotes H2A.Z was exclusively found in the transcription start sites of the polycistronic transcription units where it keeps the chromatin in an open conformation to enable RNA-polymerase II-mediated transcription. Previous studies showed the variant colocalizing with an acetylation of lysine on histone H4 and a methylation of lysine 4 on histone H3. Data indicated that HAT2 is linked to H2A.Z since it is required for acetylation of lyinse 10 on histone H4. A SWR1-like complex and a complex homologous to the NuA4/TIP60 could not be identified yet. This study aimed at identifying a SWR1-like remodelling complex in T. brucei and at identifying a protein complex orthologous to NuA4/TIP60 as well as at answering the question whether HAT2 is part of this complex or not. To this end, I performed multiple mass spectrometry-coupled co-Immunoprecipitation assays with potential subunits of a SWR1 complex, HAT2 and a putative homolog of a NuA4/TIP60 subunit. In the course of these experiments, I was able to identify the TbSWR1 complex. Subsequent cell fractionation and chromatin immunoprecipitation-coupled sequencing analysis experiments confirmed, that this complex is responsible for the incorporation of the histone variant H2A.Z in T. brucei. In addition to this chromatin remodelling complex, I was also able to identify two histone acetyltransferase complexes assembled around HAT1 and HAT2. In the course of my study data were published by the research group of Nicolai Siegel that identified the histone acetyltransferase HAT2 as being responsible for histone H4 acetylation, in preparation to promote H2A.Z incorporation. The data also indicated that HAT1 is responsible for acetylation of H2A.Z. According to the literature, this acetylation is required for proper transcription initiation. Experimental data generated in this study indicated, that H2A.Z and therefore TbSWR1 is involved in the DNA double strand break response of T. brucei. The identification of the specific complex composition of all three complexes provided some hints about how they could interact with each other in the course of transcription regulation and the DNA double strand break response. A proximity labelling approach performed with one of the subunits of the TbSWR1 complex identified multiple transcription factors, PTM writers and proteins potentially involved in chromatin maintenance. Overall, this work will provide some interesting insights about the composition of the complexes involved in H2A.Z incorporation in T. brucei. Furthermore, it is providing valuable information to set up experiments that could shed some light on RNA-polymerase II-mediated transcription and chromatin remodelling in T. brucei in particular and Kinetoplastids in general.
Tumor necrosis factor (TNF) receptor-2 (TNFR2) has attracted considerable interest as a target for immunotherapy. Indeed, using oligomeric fusion proteins of single chain-encoded TNFR2-specific TNF mutants (scTNF80), expansion of regulatory T cells and therapeutic activity could be demonstrated in various autoinflammatory diseases, including graft-versus-host disease (GvHD), experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA). With the aim to improve the in vivo availability of TNFR2-specific TNF fusion proteins, we used here the neonatal Fc receptor (FcRn)-interacting IgG1 molecule as an oligomerizing building block and generated a new TNFR2 agonist with improved serum retention and superior in vivo activity.
Methods
Single-chain encoded murine TNF80 trimers (sc(mu)TNF80) were fused to the C-terminus of an in mice irrelevant IgG1 molecule carrying the N297A mutation which avoids/minimizes interaction with Fcγ-receptors (FcγRs). The fusion protein obtained (irrIgG1(N297A)-sc(mu)TNF80), termed NewSTAR2 (New selective TNF-based agonist of TNF receptor 2), was analyzed with respect to activity, productivity, serum retention and in vitro and in vivo activity. STAR2 (TNC-sc(mu)TNF80 or selective TNF-based agonist of TNF receptor 2), a well-established highly active nonameric TNFR2-specific variant, served as benchmark. NewSTAR2 was assessed in various in vitro and in vivo systems.
Results
STAR2 (TNC-sc(mu)TNF80) and NewSTAR2 (irrIgG1(N297A)-sc(mu)TNF80) revealed comparable in vitro activity. The novel domain architecture of NewSTAR2 significantly improved serum retention compared to STAR2, which correlated with efficient binding to FcRn. A single injection of NewSTAR2 enhanced regulatory T cell (Treg) suppressive activity and increased Treg numbers by > 300% in vivo 5 days after treatment. Treg numbers remained as high as 200% for about 10 days. Furthermore, a single in vivo treatment with NewSTAR2 upregulated the adenosine-regulating ectoenzyme CD39 and other activation markers on Tregs. TNFR2-stimulated Tregs proved to be more suppressive than unstimulated Tregs, reducing conventional T cell (Tcon) proliferation and expression of activation markers in vitro. Finally, singular preemptive NewSTAR2 administration five days before allogeneic hematopoietic cell transplantation (allo-HCT) protected mice from acute GvHD.
Conclusions
NewSTAR2 represents a next generation ligand-based TNFR2 agonist, which is efficiently produced, exhibits improved pharmacokinetic properties and high serum retention with superior in vivo activity exerting powerful protective effects against acute GvHD.
Wilms tumor (WT) or nephroblastoma is the most common kidney tumor in childhood. Several genetic alterations have been identified in WT over the past years. However, a clear-cut underlying genetic defect has remained elusive. Growing evidence suggests that miRNA processing genes play a major role in the formation of pediatric tumors, including WT.
We and others have identified the microprocessor genes DROSHA and DGCR8 as key players in Wilms tumorigenesis. Exome sequence analysis of a cohort of blastemal-type WTs revealed the recurrent hotspot mutations DROSHA E1147K and DGCR8 E518K mapping to regions important for catalyic activity and RNA-binding. These alterations were expected to affect processing of miRNA precursors, ultimately leading to altered miRNA expression. Indeed, mutated tumor samples were characterized by distinct miRNA patterns. Notably, these mutations have been observed almost exclusively in WT, suggesting that they play a specific role in WT formation.
The aim of the present work was to first examine the mutation frequency of DROSHA E1147K and DGCR8 E518K in a larger cohort of WTs, and to further characterize these microprocessor gene mutations as potential oncogenic drivers for WT formation.
Screening of additional 700 WT samples by allele-specific PCR revealed a high frequency of DROSHA E1147K and DGCR8 E518K mutations, with the highest incidence found in tumors of high-risk histology. DROSHA E1147K was heterozygously expressed in all cases, which strongly implies a dominant negative effect. In contrast, DGCR8 E518K exclusively exhibited homozygous expression, suggestive for the mutation to act recessive.
To functionally assess the mutations of the microprocessor complex in vitro, I generated stable HEK293T cell lines with inducible overexpression of DROSHA E1147K, and stable mouse embryonic stem cell (mESC) lines with inducible overexpression of DGCR8 E518K. To mimic the homozygous expression observed in WT, DGCR8 mESC lines were generated on a DGCR8 knockout background. Inducible overexpression of wild-type or mutant DROSHA in HEK293T cells showed that DROSHA E1147K leads to a global downregulation of miRNA expression. It has previously been shown that the knockout of DGCR8 in mESCs also results in a significant downregulation of canonical miRNAs. Inducible overexpression of wild type DGCR8 rescued this processing defect. DGCR8 E518K on the other hand, only led to a partial rescue. Differentially expressed miRNAs comprised members of the ESC cell cycle (ESCC) and let-7 miRNA families whose antagonism is known to play a pivotal role in the regulation of stem cell properties. Along with altered miRNA expression, DGCR8-E518K mESCs exhibited alterations in target gene expression potentially affecting various biological processes.
We could observe decreased proliferation rates, most likely due to reduced cell viability. DGCR8-E518K seemed to be able to overcome the block of G1-S transition and to rescue the cell cycle defect in DGCR8-KO mESCs, albeit not to the full extent like DGCR8-wild-type. Moreover, DGCR8-E518K appeared to be unable to completely block epithelial-to-mesenchymal transition (EMT). Embryoid bodies (EBs) with the E518K mutation, however, were still able to silence the self-renewal program rescuing the differentiation defect in DGCR8-KO mESCs.
Taken together, I could show that DROSHA E1147K and DGCR8 E518K are frequent events in WT with the highest incidence in high-risk tumor entities. Either mutation led to altered miRNA expression in vitro confirming our previous findings in tumor samples. While the DROSHA E1147K mutation resulted in a global downregulation of canonical miRNAs, DGCR8 E518K was able to retain significant activity of the microprocessor complex, suggesting that partial reduction of activity or altered specificity may be critical in Wilms tumorigenesis.
Despite the significant differences found in the miRNA and mRNA profiles of DGCR8 E518K and DGCR8-wild-type mESCs, functional analysis showed that DGCR8 E518K could mostly restore important cellular functions in the knockout and only slightly differed from the wild-type situation. Further studies in a rather physiological environment, such as in a WT blastemal model system, may additionally help to better assess the subtle differences between DGCR8 E518K and DGCR8 wild-type observed in our mESC lines. Together with our findings, these model systems may thus contribute to better understand the role of these microprocessor mutations in the formation of WT.